Pages - COMAR Online
Maryland's COMAR regulations have moved to a new website (regs.maryland.gov) as of March 2026. This change does not alter the content of regulations but requires updating bookmarks and compliance monitoring processes.
Aforeworn detected this change in the Med-Spa & Aesthetics Clinics space on July 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. All med-spa and aesthetics clinics operating in Maryland, including nurse-owned, physician-owned, multi-location, and new openings. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately, but no compliance deadline as content is unchanged.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Med-Spa & Aesthetics Clinics continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The official online location of COMAR (Code of Maryland Regulations) has moved from dsd.maryland.gov to regs.maryland.gov. The regulations themselves remain unchanged.
Who it affects
All med-spa and aesthetics clinics operating in Maryland, including nurse-owned, physician-owned, multi-location, and new openings.
What you must do
Update bookmarks and internal links to point to regs.maryland.gov. Ensure compliance teams use the new URL for regulatory research.
Deadline
Immediately, but no compliance deadline as content is unchanged.
Source: https://dsd.maryland.gov/Pages/COMARHome.aspx
Never miss a change like this again
Aforeworn watches Med-Spa & Aesthetics Clinics around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Med-Spa & Aesthetics Clinics
- Welcome - Alaska Online Public Notices
- Rulemaking | SOS
- Arkansas Secretary of State
- FDA Issues Emergency Use Authorization for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats
- FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes